References
- Wiklund I, Karlberg J, Mattsson L-A. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824–30
- Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–54
- Ross L, Adler E, Cawood E, et al. Psychological effects of hormonal replacement therapy: a comparison of tibolone and sequential estrogen therapy. J Psychosom Obstet Gynecol 1999;20: 88–96
- Hilditch JR, Lewis J, Ross AH, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-1713 combined with an oral progestin on quality of life in postmenopausal women. Maturitas 1996;24: 177–84
- Soares C, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001;58: 529–34
- Nicol-Smith L. Causality, menopause, and depression: a critical review of the literature. Br Med J 1996;313:1229–32
- Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336–43
- Hammarbäck S, Bäckstrom T, Hoist J, et al. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen— progestagenpostmenopausalreplacementtherapy. Acta Obstet Gynecol Scand 1985;64: 393–7
- Björn I, Bixo M, Standberg Nöjd K, et al. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 2000;183: 1419–26
- Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994;29:319–36
- Björn I, Bäckstriim T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32:77–86
- Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189–212
- Sundström I, Nyberg S, Bixo M, etal. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999;78:891–9
- Björn I, Sundström-Poromaa I, Bixo M, et al. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab, 2003;88: 2026–30
- Björn I, Bixo M, Nöjd K, et al. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol Endocrinol 2002;16:1–8
- Seippel L, Bäckstrom T. Luteal-phase estradiol relates to symptom severity in patients with pre-menstrual syndrome. J Clin Endocrinol Metab 1998;83:1988–92
- Hoist J, Bäckström T, Hammarbäck S, etal. Pro-gestogen addition during oestrogen replacement therapy — effects on vasomotor symptoms and mood. Maturitas 1989;11:13–20
- Notelovitz M, Lenihan J, McDermott M, et al. Initial 17B-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726–31
- Greendale G, Reboussin B, Hogan P, et al. Symptom relief and side effects of postmeno-pausal hormones: results from the post-menopausal estrogen/progestin interventions trial. Obstet Gynecol 1998;92:982–8
- Dören H, Schneider HPG. Long term compliance of continuous combined estrogen and proges-tagen replacement in postmenopausal women. Maturitas 1996;25:99–105
- Wiklund I, Berg G, Hammar M, etal. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 1992;14:225–36
- Padwick ML, Siddle NC, Lane G, et al. Oestriol with oestradiol verses oestradiol alone: a comparison of endometrial, symptomatic and psychological effects. Br J Obstet Gynaecol 1986;93:606–12
- Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992;14:117–26
- Owens JF, Matthews KA. Sleep disturbance in healthy middle-aged women. Maturitas 1998;30: 41–50
- Wang M, Bäckstriim T, Sundström I, et al. Neuroactive steroids and central nervous system disorders. Int Rev Neurobiol 2001;46:421–59
- Whitehead MI, Townsend PT, Pryse-Davies J, et al. Effects of estrogens and progestins on the biochemistry and morphology of the postmeno-pausal endometrium. N Engl J Med 1981; 305:1599–605
- Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without pre-menstrual syndrome. N Engl J Med 1998;338: 209–16